🇳🇱 Netherlands Country × Condition
melanoma Clinical Trials in Netherlands
Active clinical trials for melanoma with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇳🇱 Netherlands
Active Trials in Netherlands (2)
NCT07224425 Phase 1
Recruiting
A Study of BI 3810944 in Patients With Advanced Cancer
Enrollment
69 pts
Country
🇳🇱 Netherlands
Boehringer Ingelheim
View Trial → NCT03685890 Phase 1, Phase 2
Recruiting
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
Enrollment
74 pts
Country
🇳🇱 Netherlands
Vastra Gotaland Region
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in Netherlands?
There are currently 2 active clinical trials for melanoma with sites in Netherlands, of which 2 are actively recruiting patients.
How can I join a melanoma clinical trial in Netherlands?
To join a melanoma clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in Netherlands?
Active melanoma trials in Netherlands span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology